Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/656045


The Europe Biotechnology Sectors : A Company and Industry Analysis (April 2004)


Description: Current Environment - Key Points
- A challenging economic climate has contributed to a global decline in investments and a cut in bioscience funding, placing financial pressure on Europe's biotech industry
- The biotech industry is also struggling with resistance to the use of genetically modified organisms (GMOs), in particular bio-crops
- There is healthy growth in the number of life sciences publications in four main areas: clinical medicine, basic life sciences, biomedical and biological sciences
- There is growth in the collaboration between biotech companies and pharmaceuticals
- Several areas of biotech research are being particularly targeted in the next few years: genomics and biotech for health, nanotechnology, and food quality and safety
- As investors turn away from the industry's uncertain returns, biotech companies are using mergers and acquisitions to generate cash and ensure survival and growth
- In 2002, there were only three European biotech IPOs, which raised a total of US$34.7 million (-28.45 million) - a far cry from the 2000 regional record of US$2.2 billion (-1.80 billion)

Industry Profile - Key Points
- European nations hurrying to establish home-grown biotech industries are facing challenges in obtaining venture capital, conservative attitudes towards risk and negative public opinion (particularly in the agricultural biotech field)
- The UK, Germany, France, Switzerland, the Netherlands and Scandinavian countries are leading the biotech revolution across Europe
- By mid-2003, the number of companies in the life sciences industry had grown almost four-fold to more than 1,500
- The European biotech field is focused on three emerging areas: green biotech, white biotech and healthcare biotech
- Europe spent nearly 2% of its GDP on R&D between 2000 and 2002, with the highest ratios in Sweden and Finland
- Europe's venture capital investment fell 45% to about -5.4 billion (US$6.59 billion) in 2002
- Effective April 2004, new regulations on GMOs will apply for food and feed marketed in the European Union
They cover three key areas: the authorization of GM food and feed, their labeling and the traceability of products
Market Trends and Outlook - Key Points
- The economic recession over the past two years has driven collaboration among European biotechs (and their global counterparts)
- The region is facing a shortage of researchers and experts in the field, due to many of Europe's best brains opting for better employment opportunities in North America
- Rising US-Europe trade tensions surrounding the 1998 biotech crop ban by the EU is highlighting the weakness of globalization in the industry
- The emerging nanotechnology is expected to become one of the revolutionary key research areas of the 21st century for European biotech
- With governments and industry collaborating closely, the sector seems to maintain its prominent position in this industry, and could be set to go head-to-head with its most formidable counterpart - the United States


Contents: Current Environment
- Sector Overview
- Sector Performance
- Research Priority Areas
- Mergers and Acquisitions
- The IPO Scene
Industry Profile
- Industry Overview
- Industry Size and Value
- Industry Focus Areas
- Sector Investment
- Policy and Regulatory
Environment
Market Trends & Outlook
- Agenda for International
Collaboration
- Biotech Brains Seek Greener
US Pastures
- US-Europe Trade Disputes
Affect Sector
- Nanotechnology: The Key to
Europe's Biotech Revolution
- Market Outlook
Country Profiles
- France
- Germany
- The Netherlands
- Sweden
- Switzerland
- The United Kingdom
Currency Conversion Table
The Scope of This Report
Key References
Comparative Data
Sales Contacts




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/656045

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 17/02/2012 00:55:55
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
The Europe Biotechnology Sectors : A Company and Industry Analysis (April 2004)
Web Address:
http://www.researchandmarkets.com/reports/656045
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €100.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 17/02/2012 00:55:55

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)